FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to psychiatry, and concerns treating metabolic syndrome in schizophrenic patients. That is ensured by integrated treatment including rhythmic motions for an hour 3 times a week throughout 6 months combined with introduction of neuroleptics. The second generation neuroleptics are replaced by first generation neuroleptics according to the developed scheme with considering prevailing semiology in a specific patient.
EFFECT: method provides the effective metabolic syndrome treatment combined with correction of schizophrenia symptoms in a given group of patients.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
| METHOD OF TREATING THERAPEUTICALLY RESISTANT PATIENTS WITH SCHIZOPHRENIA | 1999 |
|
RU2177326C2 |
| METHOD FOR PREDICTION OF RISK OF DELAYED DYSKINESIA ACCOMPANYING NEUROLEPTIC THERAPY IN SCHIZOPHRENICS | 2010 |
|
RU2447832C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
| APPLICATION OF TIZANIDINE AS DRUG-INDUCED PARKINSONISM CORRECTOR | 2008 |
|
RU2393860C2 |
| METHOD FOR CARRYING OUT COMBINED REDUCTION OF SCHIZO-AFFECTIVE SYNDROMES OF PSYCHOTIC AND SUBPSYCHOTIC LEVEL IN DAY CARE HOSPITAL | 2003 |
|
RU2249456C1 |
| METHOD OF TREATING SCHIZOPHRENIA | 2011 |
|
RU2484836C2 |
| LABORATORY DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR ENDOGENOUS PSYCHOSIS | 2013 |
|
RU2522236C1 |
| PREDICTION METHOD OF THERAPY EFFECTIVENESS IN PATIENTS WITH PAROXYSMAL SCHIZOPHRENIA | 2016 |
|
RU2621266C1 |
